Novel lactoferrin-functionalized manganese-doped silica hollow mesoporous nanoparticles loaded with resveratrol for the treatment of ischemic stroke
Source abstract
Abstract
Stroke is a central nervous system disease with a high incidence at present. It can cause pathological changes such as oxidative stress, inflammation, neuronal apoptosis, and lead to disturbance of consciousness, disability, and even death. Due to the existence of the blood-brain barrier (BBB), most of the drugs cannot reach the lesions and exert their efficacy fully. Therefore, the purpose of this research was to design a lactoferrin functionalized hollow mesoporous manganese doped silica nanoparticles (LHMMSN) for delivery of insoluble drug resveratrol (RES). The system could help insoluble drugs pass through the BBB and target inflammatory sites to exert the antioxidant stress, anti-inflammatory and neuroprotective effects. The RES was adsorbed into LHMMSN with a particle size of about 140 nm by adsorption method, and the drug loading reached 39.32 ± 2.46%. In vitro and in vivo experiments showed that LHMMSN-RES could increase the activity of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px), reduce brain reactive oxygen species (ROS) and malondialdehyde (MDA) content, increase the expression of anti-inflammatory factors (IL-10) and anti-apoptotic factors (bcl-2) in brain tissue, and reduce brain tissue pro-inflammatory factors (TNF-α, IL-1β, IL-6) and pro-apoptotic factors (BAX, Cleaved caspase-3) expression. In summary, LHMMSN-RES can reduce inflammation and protect nerve cells by inhibiting oxidative stress, thereby promoting the recovery of motor function in middle cerebral artery occlusion (MCAO) model rats.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Anesthesia and Neurotoxicity Research · Neuroinflammation and Neurodegeneration Mechanisms · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (55)
Show source-provided references
1. Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury
2. Cerebral ischemia-hypoxia induces intravascular coagulation and autophagy10.2353/ajpath.2006.051066 ↗
3. Oxidative stress in hypoxic-ischemic encephalopathy: molecular mechanisms and therapeutic strategies10.3390/ijms17122078 ↗
4. 6'-O-Galloylpaeoniflorin attenuates cerebral ischemia reperfusion-induced neuroinflammation and oxidative stress via PI3K/Akt/Nrf2 activation10.1155/2018/8678267 ↗
5. [Transient ischemic attacks in the elderly: new definition and diagnostic difficulties]
6. Perillyl alcohol and its drug-conjugated derivatives as potential novel methods of treating brain metastases10.3390/ijms17091463 ↗
7. Overcoming the blood-brain barrier: the role of nanomaterials in treating neurological diseases10.1002/adma.201801362 ↗
8. Improved neuroprotective effects of gallic acid-loaded chitosan nanoparticles against ischemic stroke10.1089/rej.2019.2230 ↗
9. Bioinspired nanosponge for salvaging ischemic stroke via free radical scavenging and self-adapted oxygen regulating10.1021/acs.nanolett.9b04974 ↗
10. Simultaneous blood-brain barrier crossing and protection for stroke treatment based on edaravone-loaded ceria nanoparticles10.1021/acsnano.8b01994 ↗
11. Intrathecal administration of nanoclusters for protecting neurons against oxidative stress in cerebral ischemia/reperfusion injury10.1021/acsnano.9b06780 ↗
12. The application of nanoparticles in cancer immunotherapy: targeting tumor microenvironment
13. Manganese dioxide nanosheets-based redox/pH-responsive drug delivery system for cancer theranostic application
14. Current strategies for brain drug delivery10.7150/thno.21254 ↗
15. Microvascular plasticity after experimental stroke: a molecular and MRI study10.1159/000368597 ↗
16. Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses10.1038/s41467-017-01050-0 ↗
17. Functional resveratrol-biodegradable manganese doped silica nanoparticles for the spinal cord injury treatment10.1016/j.mtbio.2021.100177 ↗
18. Proton transfer ratio, lactate, and intracellular pH in acute cerebral ischemia10.1002/mrm.21181 ↗
19. Toxicology of silica nanoparticles: an update10.1007/s00204-017-1993-y ↗
20. Mesoporous silica nanoparticles for drug and gene delivery10.1016/j.apsb.2018.01.007 ↗
21. Combination of dihydroartemisinin and resveratrol effectively inhibits cancer cell migration via regulation of the DLC1/TCTP/Cdc42 pathway10.1039/D0FO00996B ↗
22. A review on the potential of Resveratrol in prevention and therapy of diabetes and diabetic complications10.1016/j.biopha.2019.109767 ↗
23. Resveratrol neuroprotection in stroke and traumatic CNS injury10.1016/j.neuint.2015.08.009 ↗
24. Amino acid-PEGylated resveratrol and its influence on solubility and the controlled release behavior10.1248/bpb.b13-00863 ↗
25. In-vitro blood-brain barrier models for drug screening and permeation studies: an overview10.2147/DDDT.S218708 ↗
26. Neuroinflammatory mechanisms in ischemic stroke: focus on cardioembolic stroke, background, and therapeutic approaches10.3390/ijms21186454 ↗
27. Neutrophil-like cell-membrane-coated nanozyme therapy for ischemic brain damage and long-term neurological functional recovery10.1021/acsnano.0c07973 ↗
28. Crossing the blood-brain barrier with nanoparticles10.1016/j.jconrel.2017.12.015 ↗
29. Clusters of hydroxyl-functionalized cations stabilized by cooperative hydrogen bonds: the role of polarizability and alkyl chain length10.3390/molecules25214972 ↗
30. Silica nanoparticles induce alpha-synuclein induction and aggregation in PC12-cells10.1016/j.cbi.2016.09.006 ↗
31. Oxidative stress-induced DNA damage by manganese dioxide nanoparticles in human neuronal cells10.1155/2017/5478790 ↗
32. PAC proton-activated chloride channel contributes to acid-induced cell death in primary rat cortical neurons10.1080/19336950.2020.1730019 ↗
33. Socially responsive effects of brain oxidative metabolism on aggression10.1073/pnas.1412306111 ↗
34. Alterations in lipid peroxidation and antioxidant status in different types of intracranial tumors within their relative peritumoral tissues10.1016/j.clineuro.2008.11.008 ↗
35. Cell death mechanisms in stroke and novel molecular and cellular treatment options10.2174/1570159X16666180302115544 ↗
36. Global brain inflammation in stroke10.1016/S1474-4422(19)30078-X ↗
37. The interplay between inflammation, oxidative stress, DNA damage, DNA repair and mitochondrial dysfunction in depression10.1016/j.pnpbp.2017.06.036 ↗
38. Lipid peroxidation products in human health and disease 201610.1155/2017/2163285 ↗
39. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release10.1152/physrev.00026.2013 ↗
40. Effects of oxidative stress-induced changes in the actin cytoskeletal structure on myoblast damage under compressive stress: confocal-based cell-specific finite element analysis10.1007/s10237-016-0779-0 ↗
41. Oxidative stress and effect of treatment on the oxidation product decomposition processes in IBD10.1155/2018/7918261 ↗
42. Protective effects of melatonin on the activity of SOD, CAT, GSH-Px and GSH content in organs of mice after administration of SNP10.4077/CJP.2017.BAF435 ↗
43. The immunoregulatory role of myeloid-derived suppressor cells in the pathogenesis of rheumatoid arthritis10.3389/fimmu.2020.568362 ↗
44. Protocatechuic acid mitigates cadmium-induced neurotoxicity in rats: role of oxidative stress, inflammation and apoptosis10.1016/j.scitotenv.2020.137969 ↗
45. Neuroprotection by dihydrotestosterone in LPS-induced neuroinflammation10.1016/j.nbd.2020.104814 ↗
46. Hypoxia, oxidative stress and inflammation10.1016/j.freeradbiomed.2018.03.042 ↗
47. Oxidative stress in exercise training: the involvement of inflammation and peripheral signals10.1080/10715762.2019.1697438 ↗
48. Targeting mitochondrial dysfunction and oxidative stress in activated microglia using dendrimer-based therapeutics10.7150/thno.29039 ↗
49. Oxidative stress and neuronal death/survival signaling in cerebral ischemia10.1385/MN:31:1-3:105 ↗
50. Glial cells: role of the immune response in ischemic stroke10.3389/fimmu.2020.00294 ↗
51. Neurogenic inflammation after traumatic brain injury and its potentiation of classical inflammation10.1186/s12974-016-0738-9 ↗
52. Post-stroke inflammation-target or tool for therapy10.1007/s00401-018-1930-z ↗
53. Advances in smart mesoporous carbon nanoplatforms for photothermal–enhanced synergistic cancer therapy10.1016/j.cej.2022.134886 ↗
54. Current trends in smart mesoporous silica-based nanovehicles for photoactivated cancer therapy10.1016/j.jconrel.2021.10.005 ↗
55. Polydopamine-coated mesoporous silica nanoparticles for multi-responsive drug delivery and combined chemo-photothermal therapy10.1016/j.msec.2019.110103 ↗